Testing effectiveness (Phase 2)Ended earlyNCT04347226
What this trial is testing
Anti-Interleukin-8 (Anti-IL-8) for Patients With COVID-19
Who this might be right for
Solid TumorSars-CoV2Hematological Malignancy
Columbia University 43
Showing 20 of 0 results